Sugi Predict

Sugi Predict / Compounds / SCHEMBL2478161

SCHEMBL2478161

SCHEMBL2478161

Cc1c(Cl)cccc1-c1ccccc1C=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.45
▸ TSHR P16473 1/20 0.45
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ THRB P10828 1/20 0.43
▸ BLM P54132 1/20 0.43
▸ ERN1 O75460 1/20 0.40
▸ IDO1 P14902 1/20 0.40
▸ BRD4 O60885 1/20 0.38
▸ CREBBP Q92793 1/20 0.38
▸ KCNJ1 P48048 1/20 0.37
▸ TRIM24 O15164 1/20 0.36
▸ TRIM33 Q9UPN9 1/20 0.36
▸ HPGD P15428 2/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ KCNN4 O15554 1/20 0.35
▸ HSD11B1 P28845 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1547476 0.82 TDP1 (0.52) ALDH1A1TSHRMEN1KMT2ATDP1
SCHEMBL29952946 0.82 ALDH1A1 (0.50) ALDH1A1TSHRMEN1KMT2ATDP1
SCHEMBL3409591 0.82 ALDH1A1 (0.50) ALDH1A1TSHRMEN1KMT2ATDP1
SCHEMBL19960372 0.81 TDP1 (0.46) ALDH1A1TSHRMEN1KMT2ATDP1
SCHEMBL6535649 0.81 TDP1 (0.46) ALDH1A1TSHRMEN1KMT2ATDP1
SCHEMBL1830923 0.81 ALDH1A1 (0.59) ALDH1A1TSHRMEN1KMT2ATDP1
SCHEMBL10961604 0.80 ALDH1A1 (0.52) ALDH1A1TSHRMEN1KMT2ALMNA
SCHEMBL29899283 0.79 ALDH1A1 (0.52) ALDH1A1TSHRMEN1KMT2ATDP1
SCHEMBL10718432 0.79 TDP1 (0.48) ALDH1A1TSHRMEN1KMT2ATDP1
SCHEMBL8342481 0.78 TRIM24 (0.55) ALDH1A1TSHRMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2159216-B1 3-BUTENYL-1-AMINE DERIVATIVES AND THEIR USE AS Ih MODULORS FOR THE TREATMENT OF PSYCHIATIRC DISORDERS ORGANON NV (NL) 2011-10-12 — — EP disclosed
EP-2159216-A1 Ih - Modulators N.V. Organon (NL) 2010-03-03 — — EP disclosed
CN-101622227-A Biaryl and biheteroaryl compounds useful in treating iron disorders XENON PHARMACEUTICALS INC 2010-01-06 — — CN disclosed
US-20040229910-A1 Therapeutic compounds N.V. ORGANON (NL) 2004-11-18 — — US disclosed
US-20020037885-A1 Therapeutic compounds DIJCKS FREDERICUS ANTONIUS (NL) 2002-03-28 — — US disclosed
US-6313139-B1 ADMINISTERING BENZYLAMINE DERIVATIVE FOR THERAPY OF PSYCHIATRIC DISORDER IN MAMMALS AKZO NOBEL N. V. (NL) 2001-11-06 — — US disclosed
EP-1035843-A2 I h?-MODULATORS Akzo Nobel N.V. (NL) 2000-09-20 — — EP disclosed
US-6080773-A USEFUL FOR TREATMENT OF DEPRESSION, ANXIETY OR PSYCHOSIS AKZO NOBEL, N.V. (NL) 2000-06-27 — — US disclosed
WO-1999018941-A2 Ih-MODULATORS AKZO NOBEL N.V. (NL) 1999-04-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040229910-A1 Therapeutic compounds BDNF, PNMT, SLC18A2 ALDH1A1 964/4885TSHR 2499/4885MEN1 3408/4885
US-20020037885-A1 Therapeutic compounds BDNF, PNMT, SLC18A2 ALDH1A1 964/4885TSHR 2499/4885MEN1 3408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.